Transgene Biotek Ltd
BSE:526139

Watchlist Manager
Transgene Biotek Ltd Logo
Transgene Biotek Ltd
BSE:526139
Watchlist
Price: 6.7 INR 3.24% Market Closed
Market Cap: 507.7m INR
Have any thoughts about
Transgene Biotek Ltd?
Write Note

EV/FCFF
Enterprise Value to FCFF

14 078.1
Current
390.3
Median
3.6
Industry
Higher than median
Higher than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
14 078.1
=
Enterprise Value
647.6m INR
/
FCFF
46k INR
All Countries
Close
Market Cap EV/FCFF
IN
Transgene Biotek Ltd
BSE:526139
507.7m INR 14 078.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 926.9
US
Abbvie Inc
NYSE:ABBV
320.1B USD 23.8
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 31.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD -83.4
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 10.9
US
Epizyme Inc
F:EPE
94.1B EUR -473.4
AU
CSL Ltd
ASX:CSL
135.7B AUD 64.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD 22.8
US
Seagen Inc
F:SGT
39.3B EUR -57.1
NL
argenx SE
XBRU:ARGX
35B EUR -101.8

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More